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Abstract
RORa is a retinoid-related orphan nuclear receptor that regulates inflammation, lipid metabolism, and cellular differentiation
of several non-epithelial tissues. In spite of its high expression in skin epithelium, its functions in this tissue remain unclear.
Using gain- and loss-of-function approaches to alter RORa gene expression in human keratinocytes (HKCs), we have found
that this transcription factor functions as a regulator of epidermal differentiation. Among the 4 RORa isoforms, RORa4 is
prominently expressed by keratinocytes in a manner that increases with differentiation. In contrast, RORa levels are
significantly lower in skin squamous cell carcinoma tumors (SCCs) and cell lines. Increasing the levels of RORa4 in HKCs
enhanced the expression of structural proteins associated with early and late differentiation, as well as genes involved in
lipid barrier formation. Gene silencing of RORa impaired the ability of keratinocytes to differentiate in an in vivo epidermal
cyst model. The pro-differentiation function of RORa is mediated at least in part by FOXN1, a well-known pro-differentiation
transcription factor that we establish as a novel direct target of RORa in keratinocytes. Our results point to RORa as a novel
node in the keratinocyte differentiation network and further suggest that the identification of RORa ligands may prove
useful for treating skin disorders that are associated with abnormal keratinocyte differentiation, including cancer.
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Introduction
The retinoid related orphan receptor RORa belongs to the
steroid nuclear hormone receptor superfamily and functions as a
transcription factor by binding as a monomer to the RORa
responsive elements (ROREs) in the regulatory region of target
genes [1,2,3]. In humans, there are four RORa isoforms (RORa
1–4), which differ only in their amino-terminal A/B domain and
are generated by alternative promoter usage and exon splicing
[1,4]. RORa is expressed in a temporal and spatial-dependent
manner during embryonic development, and is critical for lipid
metabolism [5,6,7], inflammation, and differentiation of Purkinje
neuronal cells, adipocytes, lymphocytes, osteoblasts, as reviewed in
[2,3].
RORa is widely expressed in normal epithelial tissues [8],
including the epidermis [9,10], and is often down modulated in
epithelium-derived tumors [8]. Yet, very little is known about the
functions of RORa in epithelial cell biology. In mice, RORa
transcripts are highly expressed in the skin, specifically in
suprabasal epidermal cells, sebaceous glands, and hair follicles
[9]. Mice with homozygous disruption of the RORa gene exhibit
sparse pelage, with a slow rate of hair re-growth after shaving,
pointing to a possible role of RORa in epidermal differentiation
[9].
The epidermis is a stratified epithelial tissue structure composed
of a single basal layer of proliferating keratinocytes that become
progressively more differentiated as they migrate upwards and
transit through the overlying spinous, granular, and cornified
stratum layers [11]. The keratinocyte life cycle is associated with
well-characterized molecular and biochemical changes. Keratino-
cytes at each stage express signature structural and signaling
molecules [12]. For example, keratinocytes switch from expressing
the keratin 5/14 pair in the basal layer to keratins 1/10, followed
by involucrin, in the suprabasal layers. At later stages of
differentiation in the granular layer, keratinocytes begin to express
filaggrin and loricrin and produce lipid granules containing
cholesterol, free fatty acids, and ceramides [13].
A well-controlled transcription network is critical for the
balanced transition of keratinocytes from one stage to the next
and the long-term maintenance of skin homeostasis [11,14]. The
initial switch from basal to spinous differentiation is controlled by
Notch and p63 signaling pathways, which interplay with each
other and with other transcription factors, such as interferon
regulatory factor 6 (IRF6), AP2, and Kruppel-like factor 4 (KLF4)
[15,16,17,18,19,20] The early stage of differentiation is also
regulated by FOXN1, a member of forkhead transcription factor
family, via the interplay with the PKC and Akt signaling pathways
[21,22].
Epidermal keratinocytes provide an excellent experimental
system to study intrinsic growth/differentiation controls of
epithelial cells. Well defined culture conditions make it possible
to study primary keratinocytes of human and mouse origin in vitro
PLOS ONE | www.plosone.org 1 July 2013 | Volume 8 | Issue 7 | e70392
[23]. Experimental systems, such as organotypic culture and
grafting of cultured keratinocytes, recapitulate the complex cell-
cell interactions that occur in the epidermis in vivo [17,24,25].
Applying gain- and loss-of function approaches to the above
experimental system, we show that RORa is a key integral
element of the pro-differentiation network in epidermal keratino-
cytes, functioning as an upstream regulator of the FOXN1 gene
and genes involved in epidermal lipid/barrier functions.
Results
1) RORa4 Isoform Expression is up-regulated during
Differentiation in Human Keratinocytes, and Down-
regulated in Keratinocyte-derived Skin Cancer
To determine which RORa isoforms are expressed in
keratinocytes, conventional RT-PCR analysis was performed
using primers specific for the 4 individual isoforms. We found
that RORa4 was the predominant isoform present in human
primary keratinocytes (HKCs) cultured under growing conditions,
and upon induction of differentiation by high density or
suspension cultures [28] (Fig. 1A). While RORa1 and RORa3
were detectable in none of these conditions, low expression of
RORa2 mRNA was detected only in cells induced to differentiate
by 48-hour culture in suspension. Real time qRT-PCR analysis
using a set of primers common for all RORa isoforms, as well as
one specific for RORa4, showed a similar induction of RORa
mRNA expression upon differentiation (Fig. 1B).
The RORa2 and RORa4 proteins have different size and
electrophoretic mobility. The two proteins were clearly distin-
guished by immunoblot analysis of HKC extracts infected with
retroviruses expressing RORa2 or RORa4 cDNAs. Consistent
with the mRNA results, endogenous RORa2 protein was barely
detectable, while RORa4 expression was most prominent and
increased with the differentiation marker keratin 1 (Fig. 1C).
Immunofluorescence staining of intact human skin showed that
RORa was present in both basal and suprabasal layers (Fig. 1D,
Fig. S1). Nevertheless, the fluorescence intensity of RORa signal
in the suprabasal layers was significantly stronger than in the
keratin 14-positive cells of the basal layer (Fig. 1D). In addition,
RORa staining was mainly concentrated in the nucleus, consistent
with its function as transcription factor.
SCC development is associated with altered keratinocyte
differentiation [14,29]. RORa4 mRNA and protein levels were
reduced in a panel of skin squamous cell carcinoma (SCC) cell
lines when compared with a panel of normal HKCs (Fig. 1E, F).
Real time qRT-PCR analysis also showed a significant down-
modulation of RORa expression in a set of clinically occurring
cutaneous SCCs when compared with normal epidermis (Fig. 1G).
Immunofluorescence staining of SCC specimens revealed a
decrement of RORa expression, when compared with surround-
ing relatively normal epidermis (Fig. S2). These results further
indicate that RORa may play an important role in maintaining
skin homeostasis.
2) RORa Promotes Differentiation of Human
Keratinocytes
To determine whether RORa4 plays a role in keratinocyte
differentiation, we overexpressed RORa4 in HKC at a level
similar to that of the endogenous protein induced upon
differentiation (Fig. 1C). At 72 h after infection, increased RORa4
expression significantly induced the expression of early and
intermediate differentiation markers (keratin 1/10 and involucrin),
as well as granular layer markers (loricrin and filaggrin) at both
mRNA and protein levels (Fig. 2A).
The late stage of keratinocyte differentiation is associated with
changes in cellular metabolism, in particular lipid-related, that are
essential for epidermal outer layer formation [13]. A number of
epidermal barrier-related genes, including ALOXE3, ABCA12,
ADRP (adipose-differentiation related protein), and AQP3 (aqua-
porin 3) [30,31,32,33], were up regulated in HKCs induced to
differentiate by suspension culture (Fig. 2B), as well as by increased
RORa4 expression (Fig. 2C), implicating RORa in this aspect of
the keratinocyte differentiation program.
Increased RORa4 expression exerted no significant effect on
markers of the basal proliferative compartment (Fig. 2D). How-
ever, Alamar blue density assay showed that increased RORa4
expression caused growth inhibition in HKCs from day 6 after
transduction (Fig. 2E). The fraction of keratinocytes with clonal
growth capability was also significantly reduced after prolonged
culture (Fig. 2F). These results suggest that increased expression of
RORa4 is sufficient to promote the differentiation program while
reducing the long term growth potential of HKCs.
3) RORa is Essential for Keratinocyte Differentiation
We next investigated whether RORa is required for normal
differentiation, using a loss of function gene silencing approach.
Two separate siRNAs and a lenti-viral shRNA that target all
RORa isoforms were able to efficiently knock down RORa
expression at both mRNA and protein levels (Fig. 3A, B).
Although RORa silencing had no effect on the expression of
basal layer markers like integrin b4 and keratin 14, it significantly
reduced the expression of outer differentiation markers at mRNA
and protein levels (Fig. 3A, B). For better evaluation of late
differentiation, HKCs at growing density (72 h after siRNA
transfection) were forced to differentiate by culture in suspension
(Fig. 3C, D). RORa silencing decreased significantly the
expression of loricrin, filaggrin (Fig. 3C) and epidermal barrier-
related genes (Fig. 3D), indicating that RORa is broadly required
for keratinocyte differentiation.
To determine whether RORa plays a similar regulatory
function in vivo, HKCs infected with lenti-viruses expressing
control or RORa shRNA were injected at the dermal-epidermal
junction of immune-deficient NOD/SCID mice. As previously
reported [17,34], 8 days after injection, control cells formed well
differentiated epidermal cysts, with pronounced granular and
squamous layer formation. In contrast, RORa silencing led to
structures without ordered layer formation and cornification
(Fig. 4A). RORa expression, as assessed by immunofluorescence
analysis, was much stronger in control cysts than in those formed
by shRNA expressing keratinocytes, confirming the knockdown
efficiency in vivo (Fig. 4B). Keratin 10 was strongly expressed in
the well stratified and differentiated layers of control cysts, while
weaker expression and association with loosely connected cells
were found after RORa depletion (Fig. 4C, Fig. S3A). Loricrin
was also strongly expressed in control cysts, while it was
undetectable in the cysts formed by RORa knockdown keratino-
cytes (Fig. 4C, Fig. S3B). Oil red staining revealed that neutral
lipids were accumulated in the stratum corneum of control cysts,
but not of RORa knockdown cysts (Fig. 4D). Therefore, the
in vivo cyst assays support the in vitro findings that RORa is
required for normal keratinocyte differentiation, including the
lipid layer formation program.
4) The Pro-differentiation Effects of RORa are Partially
Mediated by FOXN1
Keratinocyte differentiation relies on an integrated transcrip-
tional network, involving increased expression and activity of the
FOXN1 and Notch1 genes. Real time qRT-PCR analysis showed
RORa Promotes Keratinocyte Differentiation
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Figure 1. RORa4 expression is induced upon keratinocyte differentiation and down-regulated in keratinocyte-derived skin SCC. (A)
RT-PCR analysis of RORa 2 and 4 expression in primary human keratinocytes (HKCs) cultured under growing (70% confluence), or differentiating
conditions as induced by 100% confluence for 1 week or suspension culture on poly HEMA-coated dishes for 24 or 48 h. GAPDH was used as an
internal control. (B) Real time qRT-PCR analysis of HKCs with primers specific for RORa4 or for all RORa isoforms. Values are normalized to 36B4, and
presented as mean fold-change over control 6 S.E.M., ***, p,0.001, N = 4 batches of HKCs. (C) Western blot analysis of RORa in HKCs under growing
versus differentiating conditions. Lysates from sub-confluent HKCs infected with RORa2 or RORa4 expressing retroviruses were used as an indicator
of the migration rate of the two isoforms in gels. Keratin 1 and c-tubulin were used as indicators of differentiation and loading control, respectively.
(D) Immunofluorescence analysis of RORa expression in human skin. Frozen sections (8 mm) of normal human skin were co-stained with antibodies
against RORa (green) and keratin 14 (red). DNA was with counterstained with Hoechst (blue). Images are representatives of several independent
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that mRNA expression of FOXN1 and Notch1 was significantly
induced by increased expression of RORa4 (Fig. 5A), and
decreased by RORa silencing (Fig. 5B). In contrast, RORa level
did not affect the expression of other transcription factors (p53, c-
myc, and NF-kB) (Fig. S4). Mat-Inspector software (Genomatrix)
was used to analyze the transcription regulatory region of these
genes, spanning 6 kb of upstream and 2 kb of downstream
sequence from the transcription start sites (TSS). Multiple
consensus RORa response elements (ROREs) were found in both
FOXN1 and Notch1 regulatory regions. Chromatin Immunopre-
cipitation (ChIP) analysis of human epidermis by real time RT-
PCR showed binding of endogenous RORa to an upstream region
of the FOXN1 gene containing a predicted RORa binding site (–
4.8 kb), but not to a downstream region containing another such
site (+1.6 kb) (Fig. 5C). Despite the presence of predicted ROREs,
ChIP assays failed to detect any significant binding of RORa to
the Notch1 promoter region. Consistent with FOXN1 functioning
as a direct RORa target, expression of the primary FOXN1
transcript, as detected by the primers corresponding to the first
intron/exon junction, was similarly induced or blocked by
modulation of RORa as the mature transcript (Fig. 5D).
To assess whether FOXN1 functions as a mediator RORa in
differentiation, we tested the impact of increased RORa4
expression in HKCs plus/minus FOXN1 silencing (Fig. 6).
Induction of early differentiation markers keratin 1/10 and
Notch1 by increased RORa expression was counteracted to a
large extent by siRNA-mediated FOXN1 knockdown (Fig. 6A).
FOXN1 silencing showed opposite enhancing effects on expres-
sion of filaggrin (Fig. 6B), consistent with previous findings that
FOXN1 functions as repressor rather inducer of late keratinocyte
differentiation markers [22]. Selective effects of FOXN1 knock-
down were also observed with the epidermal barrier-related genes.
Silencing of FOXN1 blocked the ability of RORa to induce ADFP
and AQP3 expression, while causing no repression or even slight
fields (see more in Fig. S1), bar = 50 mm Fluorescence intensity of RORa/cell was quantified in 100 cells (from 3 human skin samples) in K14 positive
basal versus negative (suprabasal) keratinocytes. Data are presented as mean fold-change of fluorescence signal/cell over signal/cell in basal layer 6
S.E.M., ***, p,0.001, N = 3 human skin samples. (E–F) Real time qRT-PCR (E) and western blot analysis (F) of RORa in HKCs (N= 5 batches), in parallel
with keratinocyte-derived skin SCC12 and SCC13, as well oral SCCO12, SCCO22, and SCCO28 cell lines. Primers specific for RORa4 or all RORa isoforms
were used for the RT-PCR analysis. Values are normalized to 36B4, and presented as mean fold-change over HKCs 6 S.E.M. **, p,0.05 ***, p,0.001,
N = 3. (G) Real time qRT-PCR analysis of RORa expression in clinically occurring skin SCC tumors versus normal epidermis (NS), ****, p,0.0001.
doi:10.1371/journal.pone.0070392.g001
Figure 2. Increased expression of RORa4 triggers differentiation and inhibits proliferation of HKCs. (A) Real time qRT-PCR and western
blot analysis of differentiation markers in HKCs at 72 h after infection with retroviruses expressing RORa4 or GFP alone. The mRNA level of each gene
is normalized for 36B4 expression, and presented as mean fold-change over control 6 S.E.M., ***, p,0.001, N = 3. (B) RT-PCR analysis of the indicated
genes in HKCs under growing versus differentiating conditions as induced by suspension culture for 24 hours. Results are presented as mean fold-
changes over control 6 S.E.M., ***, p,0.001, N= 3. (C–D) Real time qRT-PCR analysis of the indicated genes in samples from (A). Data are presented
as mean fold-change over controls 6 S.E.M., ***, p,0.001, N= 3. (E) Alamar blue cell proliferation assay of HKCs in response to elevated RORa4
expression. Data are presented as mean fold-change of fluorescence intensity 6 S.E.M. over control cells at day 2 after infection. **, p,0.01, N= 3. (F)
Clonogenicity assay of HKCs in response to increased RORa4 expression. HKCs expressing RORa4 or GFP alone were analyzed for colony formation
after 9 days of culture. Data are presented as mean percentage-change 6 S.E.M. over control cells. ***, p,0.001, N = 3.
doi:10.1371/journal.pone.0070392.g002
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Figure 3. Silencing of RORa expression inhibits keratinocyte differentiation. (A) Real time RT-PCR and western blot expression analysis of
the expression of indicated genes in HKCs transfected with two separate siRNAs against all RORa isoforms or control siRNA. Cells were harvested at
day 4 after transfection when they reached 100% confluence. mRNA levels were normalized for 36B4, and presented as mean fold-change over
control 6 S.E.M. ***, p,0.001, N = 3. (B) Real time qRT-PCR and western blot analysis of indicated gene products in HKCs infected with lentiviruses
expressing control shRNA or an shRNA against RORa. Cells were harvested 4 days after infection. Values are presented as mean fold-change over
control6 S.E.M. **, p,0.01, ***, p,0.001, N= 3. (C) Western blot analysis of loricrin and filaggrin expression in HKCs transfected with control or RORa
siRNAs. Seventy-two hours after transfection, sub-confluent cells were re-plated onto poly-HEMA coated plates, and harvested after 20 h culture in
RORa Promotes Keratinocyte Differentiation
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up-regulation of ALOXE3 and ABCA12 (Fig. 6C). These results
establish FOXN1 as a direct RORa target and selective mediator
of its function in differentiation.
Discussion
The nuclear orphan receptor RORa plays a key role in
embryonic development and a variety of physiological processes,
such as lipid metabolism, bone formation, inflammation and TH17
cell differentiation [6,35] [3]. In parallel with its inverse expression
in normal keratinocytes and epidermis versus SCC cells and
tumors, we have shown here that RORa plays an essential positive
role in keratinocyte differentiation, with FOXN1 as a direct target
and mediator. RORa4 is the major RORa isoform expressed in
keratinocytes, and its expression is further induced upon differen-
tiation at both mRNA and protein levels. In contrast to Notch1
and FOXN1, which promote early stages of keratinocyte
differentiation and suppress the later ones [21,36,37], RORa4 is
a positive determinant of both, with a role that extends to control
of a group of genes that are involved in lipid synthesis, lipid
delivery to lamellar bodies, lipid deposition/release from droplets,
and water/glycerol transport [33,38,39,40,41,42].
FOXN1 is a key player in the epidermal differentiation program
[21,22], hair follicle development [43], and skin pigmentation
[44]. Moreover, we have previously reported that it functions as a
determinant of benign versus malignant keratinocyte tumor
development [27]. Little is known of the upstream factors that
regulate FOXN1 expression in keratinocyte differentiation, except
that it appears to be a direct negative target of the c-Jun
transcription factor, and under opposite control of EGFR/ERK
versus FGFR3 signaling [27,37]. We have shown here that RORa
can also directly bind to the regulatory region of the FOXN1 gene
and induce its transcription. The findings are of functional
importance, as silencing of FOXN1 prevented the ability of
RORa4 to induce expression of a number of differentiation
marker genes, as well as a few of the genes involved in epidermal/
lipid barrier formation. Importantly, the ability of RORa to
induce expression of Notch1, another key regulator of keratinocyte
differentiation [29], was also prevented by the FOXN1 knock-
down, consistent with a previous finding that FOXN1 is required
to maintain Notch1 expression in the hair follicle matrix of mice
[45]. In contrast to these genes, induction of filaggrin by RORa4
was enhanced rather than prevented by knocking down FOXN1,
consistent with the already mentioned negative impact of this gene
on late stages of differentiation [21,37]. FOXN1 knockdown did
not affect RORa4-induced expression of specific genes connected
with the lipid barrier function like ALOXE3 and ABCA12. This
indicates that RORa functions as inducer of keratinocyte
suspension. (D) Real time qRT-PCR analysis of the indicated lipid/epidermal barrier related genes in HKCs plus/minus RORa knockdown as in (C).
Values are presented as mean fold-change over control 6 S.E.M. **, p,0.01, ***, p,0.001, N= 3.
doi:10.1371/journal.pone.0070392.g003
Figure 4. Silencing of RORa disrupts keratinocyte differentiation in vivo. HKCs stably infected with lentiviruses expressing shRNAs against
RORa or control were injected intradermally into the back skin of NOD/SCID mice. To minimize the individual variation, control and RORa knockdown
cells were injected in parallel in the right and left flank of mice. Resting nodules/cysts formed from HKCs were collected on day 8 after injection, and
frozen sections were analyzed by (A) Hematoxylin & Eosin staining; (B–C) Immunofluorescence for the indicated proteins; or (D) oil red and
hematoxylin staining to visualize lipids (red) and for nuclei (blue). Bar = 50 mm.
doi:10.1371/journal.pone.0070392.g004
RORa Promotes Keratinocyte Differentiation
PLOS ONE | www.plosone.org 6 July 2013 | Volume 8 | Issue 7 | e70392
differentiation through both FOXN1-dependent and -independent
mechanisms. Such a conclusion is consistent with a recent report
that filaggrin gene expression is positively controlled by RORa
through an as yet undefined AP1-dependent mechanism [46].
A number of lipid products have been identified as natural or
synthetic ligands or agonists/antagonists of RORa [47], including
cholesterol sulfate [48,49,50], which is formed during squamous
differentiation and may be involved in induction of RORa activity
in the skin [46,50]. In general, nuclear receptors function as
intracellular sensors of various lipids (Evans 2004) and, in addition
to being part of the structural component, lipids can serve as
signaling molecules for nuclear receptors involved in establishment
of the epidermal barrier [51]. Thus, by inducing lipid metabolizing
genes, enhanced RORa expression has the potential of modulat-
ing lipid molecules involved in its own regulation and/or
regulation of other nuclear hormone receptors with a role in the
skin. In particular, ALOXE3, a target gene of RORa, encodes an
epidermal specific lipoxygenase eLOX3, which acts as a hydro-
peroxide isomerase and generates specific types of epoxyalchols
(hepoxilins) [52,53]. Hypoxylins have been shown to bind and
activate PPARa [38], and thus may mediate a cross talk with
RORa function.
As reported in other epithelial tumors [8], we have found that
RORa expression is down-regulated in keratinocyte-derived SCC
cell lines and tumors. However, the causes of RORa low
expression in SCCs are still unknown. One attractive possibility
is that p53, often lost or mutated in skin SCCs, is positively
controlling RORa, as already reported in colon cancer cell lines
[54]. In this context, RORa acts as a positive feedback loop on
p53 stability and pro-apoptotic functions [54,55]. In our own
work, we have also obtained evidence that RORa expression can
be positively controlled by p53, even though this was not observed
in all tested conditions and with different human keratinocyte
strains (unpublished results).
Besides genetic heterogeneity of response, another level of
complexity that still has to be deciphered in further studies is the
connection between RORa and control of the circadian cycle. In
fact, RORa is also known to play a role in the circadian cycle [56],
and a cross-talk between this and cell cycle control is currently
emerging as an important element of cancer susceptibility [57]. It
has also been reported that the circadian clock temporally fine-
Figure 5. RORa positively regulates the expression of FOXN1. (A–B) HKCs with increased (A) or knocked-down (B) RORa expression were
analyzed for expression of mature FOXN1 and Notch1 mRNA by real time qRT-PCR. Values are presented as mean fold-change over control 6 S.E.M.,
***, p,0.001, N = 3. (C) Chromatin immuno-precipitation (ChIP) analysis of RORa binding to the regulatory region of the FOXN1 gene. Mat-inspector
software was used to search for RORa response elements (ROREs) within –6 kb and +2 kb from the transcription starting site (TSS) [Top]. Human
epidermis was processed for ChIP assays utilizing rabbit antibodies specific for RORa or non-immune IgG control followed by PCR amplification of the
indicated regulatory regions of the FOXN1 gene. The relative amount of precipitated DNA was calculated after normalization for total input
chromatin, according to the following formula [59]: % total = 2DCt65, where DCt = Ct (input) – Ct (immunoprecipitation), Ct, cycle threshold. Statistical
significance of the results was determined by unpaired Student’s t-test, comparing the ratio RORa/IgG signal for each binding site relative to the one
for the binding site at the RORE negative region. **, p,0.01, N = 3. (D) HKCs with increased or knocked down RORa expression were analyzed by qRT-
PCR for primary FOXN1 transcript levels, using a primer corresponding to the first intron/exon junction. Samples were the same as described in (A–B).
Values are presented as mean fold-change over control 6 S.E.M., ***, p,0.001, N = 3.
doi:10.1371/journal.pone.0070392.g005
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tunes the self renewal potential of epidermal stem cells [58]. Thus,
besides its clear role in keratinocyte differentiation, RORa may
play additional functions in the skin, depending on growth/
differentiation stages of keratinocytes and/or in response to
multiple exogenous signals.
Materials and Methods
Ethics Statement
The animal study (protocol #: 2004N000170) was specifically
approved by the Subcommittee on Research Animal Care
(SRAC), which serves as the Institutional Animal Care and Use
Committee (IACUC) in Massachusetts General Hospital. The
animal study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
surgery was performed under sodium pentobarbital anesthesia,
and all efforts were made to minimize suffering.
Cell Culture and Human Specimens
Primary human keratinocytes were isolated and cultured in
serum-free keratinocyte-SFM medium (Gibco) supplemented with
30 mg/ml bovine pituitary extract (BPE) and 0.2 ng/ml rEGF on
the collagen coated plates. Suspension induced differentiation was
achieved by culturing HKCs on the poly (2-hydroxyethylmetha-
crylate) [poly-HEMA] (Sigma) coated Petri dishes for 24 or 48
hours. SCC13 and SCC12 cell lines were provided by Dr. J.
Rheinwald (Brigham and Women’s Hospital), and the SCC O12,
O22 and O28 cells were provided by Dr. J. Rocco (Massachusetts
General Hospital). The information of skin SCC samples is
described previously [17].
Plasmids and Viruses
The retroviral pinco-Flag-RORa2 and pinco-Flag-RORa4
plasmids were generated by cloning the Flag-tagged full-length
cDNAs of the two human RORa isoforms into the BamHI/EcoRI
sites of the pinco-GFP vector. The cDNAs with restriction enzyme
sites were generated from PCR using pcDNA-RORa2 and pCR-
BluntII-TOPO-RORa4 plasmids (Open Biosystems) as templates,
as well as the following primers 1) Forward for RORa4:59-
GATTCCGGATCCGCCACCATGGACTACAAGGACGAC-
GATGACAAGATGATGTATTTTGTGATCGCAGCG; 2)
Forward for RORa2:59- GATTCCGGATCCGCCAC-CATG-
GACTACAAGGACGACGATGACAAGATGAAT-
GAGGGGGCCCCAGGAGAC; 3) Reverse for both RORa2 and
RORa4:59- GCTGCTGAATTCCTATTACCCATCAA-
TTTGCATTGCTGG. The lentiviral MISSION shRNA against
all RORa isoforms is obtained from Sigma (TRCN0000022154).
Conditions for retro- and lenti-virus production and infection were
as previously reported [26].
Figure 6. RORa-induced keratinocyte differentiation is partially mediated by FOXN1. (A–C) HKCs transfected with control siRNA or siRNA
against FOXN1 were infected with retroviruses expressing GFP or RORa4 24 hours later. Samples were collected after additional 72 hours for qRT-PCR
or western blot analysis of the indicated genes. qRT-PCR data are presented as mean fold-change over controls 6 S.E.M. ***p,0.001, **p,0.01,
*p,0.05, N= 3.
doi:10.1371/journal.pone.0070392.g006
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Quantitative Real Time RT PCR and Microarray Analysis
For mRNA analysis, 500 mg of total RNA, isolated with RNeasy
Mini QIAcube kit (Qiagen), was reversely transcribed into cDNA
using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA,
USA). The PCR procedure and primers for RORa 1–4 isoforms
were as described previously (Pozo et al. 2004). qRT-PCR with
SYBR Green detection (Roche Applied Science, Indianapolis, IN,
USA) was performed on the Light Cycler 480 Real Time PCR
instrument (Roche Applied Science), according to manufacturer’s
instructions. Each sample was tested in triplicate, and results were
normalized with the expression of the housekeeping 36b4 gene.
The list of gene-specific primers for qRT-PCR is provided in
Table S1.
Fluorescence Microscopy and Histological Analysis
Frozen blocks of specimens were sectioned and fixed with 4%
paraformaldehyde in PBS at room temperature for 30 min. After
permeablization with 0.1% NP-40/PBS, slides were blocked with
5% normal donkey serum/PBS and incubated with the primary
antibodies in the blocking buffer at 4uC overnight. After washes
with 0.1% NP-40/PBS, slides were incubated with Alexa 488
(green)- or Alexa 594 (red)-conjugated secondary antibodies
(Invitrogen, Grand Island, NY, USA), plus Hoechst (Invitrogen)
for DNA detection. Fluorescence microscopy was carried with
Nikon TE300 inverted fluorescence microscope. The primary
antibodies include: rabbit anti-RORa (ab60134, Abcam, Cam-
bridge, MA, USA), rat anti-integrin a6 (CD49f, Chemicon
International Inc., Temecula, CA, USA), mouse anti-keratin 14
(ab9220, Abcam), rabbit anti-keratin 1 (PRB-149P, Covance,
Dedham, MA, USA), rabbit anti-keratin 10 (PRB-159P, Covance),
mouse anti-involucrin (I9018, Sigma, St. Louis, MO, USA), rabbit
anti-loricrin (PRB-145P, Covance), and rabbit anti-Ki67
(ab16667, Abcam). For histological analysis, frozen sections were
fixed with 10% formalin, and stained with Haematoxylin & Eosin
(Protocols, kalamazoo, MI, USA). Bright field images were
collected with Zeiss Axio Observer Z1 inverted microscope. The
average fluorescence intensity of RORa signal in each cell was
quantified by the Image J software.
Western Blot Analysis
Conditions for immuno-blotting were as previously described,
with the same antibodies listed for fluorescence microscopy, except
rabbit anti-RORa (sc-28612, Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA). As loading controls, membranes blotted
with rabbit antibodies were incubated with blocking buffer
containing 0.2% sodium azide and were re-probed with mouse
anti-c-tubulin (GTU-88, Sigma) antibody.
Alamar Blue Assay
Cell proliferation was measured by the Alamar Blue assay
(Invitrogen). HKCs were plated in triplicate on the 96-well
collagen coated plates at a density of 1000 cells/well in 100 ml
medium. At the specific time points, 5 ml of Alarma Blue reagent
was added to the medium for 1 hour at 37uC. Fluorescence was
monitored at 530–560 nm excitation wavelength and 590 nm
emission wavelength on the VictorTM X3 Multilabel Plate Reader
(Perkin Elmer, Salem, MA, USA).
Clonogenicity Assay
HKCs were plated at a density of 1000 cells/well in the 6-well
plates without collagen coating. Nine days later, cells were fixed
with 100% ethanol for 10 min at RT, followed by staining with
0.1% crystal violet in 10% ethanol at RT for 1 hour. After washes
in water, the plates were dried at RT overnight. Colonies were
counted with the Image J software.
SiRNA Transfection
Primary human keratinocytes were reversely transfected with
40 nM of predesigned siRNAs (Ambion-Invitrogen) for human
RORa (s12103, s12105), FOXN1 (s16062, s16060), and control
(4390844) using Hiperfect reagent (Qiagen), according to manu-
facture’s instructions.
Cyst Assay
For in vivo cyst assays, HKCs infected with lenti-virus expressing
control or RORa shRNAs were selected by puromycin 2 days
after infection. After selection, cells were collected and admixed
with matrigel (4:1), followed by intra-dermal injection (26106 cells
per spot) into the back skin of NOD/SCID mice (Taconic Farms
Inc. Germantown, NY, USA), as previously described [17]. To
minimize the individual animal variations, HKCs plus/minus
RORa knockdown were injected in parallel in the right and left
flank of the same mice. Mice were sacrificed 1 week after injection
and the nodules formed from HKCs were processed to make
frozen blocks with OCT (Fisher Scientific, Hanover Park, IL,
USA).
Chromatin Immunoprecipitation (ChIP)
Human epidermis was separated from the underlying dermis by
a brief heat treatment [27]. The finely minced tissue samples were
then cross-linked with 1% formaldehyde/PBS at RT for 10 min,
followed by addition of 125 mM glycine. After washes in PBS, the
tissue pellets were processed for chromatin immunoprecipitation
(ChIP) assays as described in [26], using the ChIP assay kit
(Millipore) and the rabbit anti-RORa antibody (ab60134, Abcam),
in parallel with the affinity-purified non-immune rabbit IgG. The
relative amount of precipitated DNA was analyzed by qRT-PCR
using primers against the RORE-containing or RORE-negative
regions, and calculated after normalization to total input
chromatin, according to the formula: % total = 2DCt65, where
DCt=Ct (input) – Ct (immunoprecipitation), Ct, cycle threshold.
Statistics
All statistical evaluations were carried out using GraphPad
Prism 5.0. All analyses are unpaired two-tailed Student’s t-test.
Real-time RT-PCR samples were tested in triplicate, and repeated
at least three times. After normalization to the housekeeping gene
36b4, combined data was represented as mean-fold over control6
S.E.M. P-values,0.05 were considered significant.
Supporting Information
Figure S1 Immunofluorescence analysis of RORa in
human skin. Frozen sections (8 mm) of normal human skin were
co-stained with antibodies against RORa (green) and keratin 14
(red). DNA was counterstained with Hoechst (blue). Images are
representatives of independent fields from 2 skin samples, derived
from different patients, as in Fig. 1D, bar = 50 mm.
(TIF)
Figure S2 Immunofluorescence analysis of RORa in
human skin SCC specimens. (A–B) Frozen sections (8 mm) of
skin SCC samples were stained with the antibody against RORa
(green). DNA was counterstained with Hoechst (blue). (A) Top
panel: low magnification (10x) of images showing both normal
epidermis and SCC lesions from specimen #1. Lower panel: high
magnification (20x) of selected areas (a, SCC lesion; b, epidermis)
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of top panel. (B) High magnification (20x) of RORa staining in
epidermis and skin SCC lesion from specimen #2. Bar = 50 mm.
(TIF)
Figure S3 Silencing of RORa disrupts keratinocyte
differentiation in vivo. Puromycin selected HKCs harboring
lentivirus expressing control or RORa shRNAs were injected
intradermally into the back skin of NOD/SCID mice as in Fig. 4.
Resulting nodules/cysts were collected on day 8 after the injection,
and frozen sections were analyzed for expression of K10 (green)/
integrin a6 (red) [A], or loricrin (green)/integrin a6 (red) [B].
DNA was counterstained with Hoechst (blue). Shown are the
results determined from 4 different mice besides the ones shown in
Fig. 4. Upper bar = 100 mm, lower bar = 50 mm.
(TIF)
Figure S4 RORa does not affect the expression of
transcription factors, including p53, c-myc, and NF-kB
in HKCs. HKCs with increased (A) or knocked-down (B) RORa
expression were analyzed for expression of individual transcription
factors by real time qRT-PCR. Values are presented as mean fold-
change over control 6 S.E.M, N=3.
(TIF)
Table S1 Primer information.
(PDF)
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